The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADAPTIVE BIOTECHNOLOGIES COR | COM | 00650F109 | 6,651,701 | 1,357,490 | SH | SOLE | NONE | 1,357,490 | 0 | 0 | |
| ALECTOR INC | COM | 014442107 | 26,527,978 | 3,324,308 | SH | SOLE | NONE | 3,324,308 | 0 | 0 | |
| ALIGN TECHNOLOGY INC | COM | 016255101 | 40,089,762 | 146,313 | SH | SOLE | NONE | 146,313 | 0 | 0 | |
| ALPHATEC HLDGS INC | NOTE 0.750% 8/0 | 02081GAB8 | 28,368,375 | 26,750,000 | PRN | SOLE | NONE | 26,750,000 | 0 | 0 | |
| AMGEN INC | COM | 031162100 | 16,762,764 | 58,200 | SH | SOLE | NONE | 58,200 | 0 | 0 | |
| APOGEE THERAPEUTICS INC | COM | 03770N101 | 19,029,962 | 681,101 | SH | SOLE | NONE | 681,101 | 0 | 0 | |
| ARGENX SE | SPONSORED ADR | 04016X101 | 58,283,398 | 153,204 | SH | SOLE | NONE | 153,204 | 0 | 0 | |
| ASCENDIS PHARMA A/S | NOTE 2.250% 4/0 | 04351PAD3 | 130,386,668 | 126,897,000 | PRN | SOLE | NONE | 126,897,000 | 0 | 0 | |
| BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 34,253,677 | 5,718,477 | SH | SOLE | NONE | 5,718,477 | 0 | 0 | |
| BRIDGEBIO PHARMA INC | NOTE 2.500% 3/1 | 10806XAB8 | 138,406,149 | 114,338,000 | PRN | SOLE | NONE | 114,338,000 | 0 | 0 | |
| BRIDGEBIO PHARMA INC | NOTE 2.250% 2/0 | 10806XAD4 | 57,327,759 | 67,294,000 | PRN | SOLE | NONE | 67,294,000 | 0 | 0 | |
| COMPASS THERAPEUTICS INC | COM | 20454B104 | 495,707 | 317,761 | SH | SOLE | NONE | 317,761 | 0 | 0 | |
| CULLINAN ONCOLOGY INC | COM | 230031106 | 12,644,414 | 1,240,865 | SH | SOLE | NONE | 1,240,865 | 0 | 0 | |
| CUTERA INC | NOTE 2.250% 6/0 | 232109AD0 | 8,373,750 | 31,900,000 | PRN | SOLE | NONE | 31,900,000 | 0 | 0 | |
| CUTERA INC | NOTE 4.000% 6/0 | 232109AG3 | 6,543,125 | 29,000,000 | PRN | SOLE | NONE | 29,000,000 | 0 | 0 | |
| DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | 61,547,366 | 4,215,573 | SH | SOLE | NONE | 4,215,573 | 0 | 0 | |
| DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 7,473,082 | 7,843,285 | SH | SOLE | NONE | 7,843,285 | 0 | 0 | |
| DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 18,863,874 | 1,169,490 | SH | SOLE | NONE | 1,169,490 | 0 | 0 | |
| DENALI THERAPEUTICS INC | COM | 24823R105 | 9,909,563 | 461,769 | SH | SOLE | NONE | 461,769 | 0 | 0 | |
| DEXCOM INC | NOTE 0.250%11/1 | 252131AK3 | 47,205,000 | 45,000,000 | PRN | SOLE | NONE | 45,000,000 | 0 | 0 | |
| DYNE THERAPEUTICS INC | COM | 26818M108 | 10,052,286 | 755,811 | SH | SOLE | NONE | 755,811 | 0 | 0 | |
| EXACT SCIENCES CORP | NOTE 0.375% 3/0 | 30063PAC9 | 123,140,000 | 131,000,000 | PRN | SOLE | NONE | 131,000,000 | 0 | 0 | |
| GLAUKOS CORP | COM | 377322102 | 19,296,992 | 242,760 | SH | SOLE | NONE | 242,760 | 0 | 0 | |
| GUARDANT HEALTH INC | COM | 40131M109 | 20,529,002 | 758,928 | SH | SOLE | NONE | 758,928 | 0 | 0 | |
| GUARDANT HEALTH INC | NOTE 11/1 | 40131MAB5 | 189,117,660 | 268,252,000 | PRN | SOLE | NONE | 268,252,000 | 0 | 0 | |
| HARROW INC | COM | 415858109 | 16,784,141 | 1,498,584 | SH | SOLE | NONE | 1,498,584 | 0 | 0 | |
| HILLEVAX INC | COM | 43157M102 | 3,264,682 | 203,407 | SH | SOLE | NONE | 203,407 | 0 | 0 | |
| IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 41,768,457 | 611,365 | SH | SOLE | NONE | 611,365 | 0 | 0 | |
| INSMED INC | NOTE 1.750% 1/1 | 457669AA7 | 56,123,264 | 52,388,000 | PRN | SOLE | NONE | 52,388,000 | 0 | 0 | |
| INSPIRE MED SYS INC | COM | 457730109 | 37,564,977 | 184,658 | SH | SOLE | NONE | 184,658 | 0 | 0 | |
| INSULET CORP | NOTE 0.375% 9/0 | 45784PAK7 | 72,702,000 | 63,000,000 | PRN | SOLE | NONE | 63,000,000 | 0 | 0 | |
| INVITAE CORP | NOTE 2.000% 9/0 | 46185LAB9 | 14,850,554 | 16,781,000 | PRN | SOLE | NONE | 16,781,000 | 0 | 0 | |
| IONIS PHARMACEUTICALS INC | NOTE 4/0 | 462222AD2 | 5,538,680 | 5,240,000 | PRN | SOLE | NONE | 5,240,000 | 0 | 0 | |
| IRHYTHM TECHNOLOGIES INC | COM | 450056106 | 60,815,525 | 568,157 | SH | SOLE | NONE | 568,157 | 0 | 0 | |
| IRONWOOD PHARMACEUTICALS INC | NOTE 0.750% 6/1 | 46333XAF5 | 39,478,223 | 37,509,000 | PRN | SOLE | NONE | 37,509,000 | 0 | 0 | |
| IRONWOOD PHARMACEUTICALS INC | NOTE 1.500% 6/1 | 46333XAH1 | 16,871,750 | 15,500,000 | PRN | SOLE | NONE | 15,500,000 | 0 | 0 | |
| KARYOPHARM THERAPEUTICS INC | NOTE 3.000%10/1 | 48576UAA4 | 32,987,982 | 65,976,000 | PRN | SOLE | NONE | 65,976,000 | 0 | 0 | |
| KEROS THERAPEUTICS INC | COM | 492327101 | 44,489,889 | 1,118,961 | SH | SOLE | NONE | 1,118,961 | 0 | 0 | |
| KRYSTAL BIOTECH INC | COM | 501147102 | 24,340,572 | 196,200 | SH | SOLE | NONE | 196,200 | 0 | 0 | |
| LANTHEUS HLDGS INC | COM | 516544103 | 30,696,200 | 495,100 | SH | SOLE | NONE | 495,100 | 0 | 0 | |
| LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | 33,851,642 | 562,600 | SH | SOLE | NONE | 562,600 | 0 | 0 | |
| MARAVAI LIFESCIENCES HLDGS I | COM CL A | 56600D107 | 33,016,159 | 5,040,635 | SH | SOLE | NONE | 5,040,635 | 0 | 0 | |
| MERUS N V | COM | N5749R100 | 10,193,673 | 370,679 | SH | SOLE | NONE | 370,679 | 0 | 0 | |
| MINERALYS THERAPEUTICS INC | COM | 603170101 | 17,405,540 | 2,023,900 | SH | SOLE | NONE | 2,023,900 | 0 | 0 | |
| NANOSTRING TECHNOLOGIES INC | NOTE 2.625% 3/0 | 63009RAD1 | 2,724,718 | 3,650,000 | PRN | SOLE | NONE | 3,650,000 | 0 | 0 | |
| NEOGENOMICS INC | NOTE 1.250% 5/0 | 64049MAA8 | 9,375,000 | 10,000,000 | PRN | SOLE | NONE | 10,000,000 | 0 | 0 | |
| NEOGENOMICS INC | NOTE 0.250% 1/1 | 64049MAB6 | 50,199,537 | 65,601,000 | PRN | SOLE | NONE | 65,601,000 | 0 | 0 | |
| NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 94,235,938 | 715,209 | SH | SOLE | NONE | 715,209 | 0 | 0 | |
| NEVRO CORP | COM | 64157F103 | 38,227,439 | 1,776,368 | SH | SOLE | NONE | 1,776,368 | 0 | 0 | |
| NOVOCURE LTD | NOTE 11/0 | 67011XAB9 | 117,917,495 | 135,834,000 | PRN | SOLE | NONE | 135,834,000 | 0 | 0 | |
| NUVASIVE INC | NOTE 0.375% 3/1 | 670704AJ4 | 74,288,925 | 80,530,000 | PRN | SOLE | NONE | 80,530,000 | 0 | 0 | |
| ORTHOPEDIATRICS CORP | COM | 68752L100 | 36,013,603 | 1,107,770 | SH | SOLE | NONE | 1,107,770 | 0 | 0 | |
| OUTSET MED INC | COM | 690145107 | 12,986,310 | 2,400,427 | SH | SOLE | NONE | 2,400,427 | 0 | 0 | |
| PARAGON 28 INC | COM | 69913P105 | 41,787,472 | 3,361,824 | SH | SOLE | NONE | 3,361,824 | 0 | 0 | |
| PENUMBRA INC | COM | 70975L107 | 56,041,100 | 222,792 | SH | SOLE | NONE | 222,792 | 0 | 0 | |
| PULMONX CORP | COM | 745848101 | 10,046,414 | 787,954 | SH | SOLE | NONE | 787,954 | 0 | 0 | |
| RAPT THERAPEUTICS INC | COM | 75382E109 | 9,674,105 | 389,300 | SH | SOLE | NONE | 389,300 | 0 | 0 | |
| REPLIGEN CORP | COM | 759916109 | 18,465,100 | 102,698 | SH | SOLE | NONE | 102,698 | 0 | 0 | |
| SAREPTA THERAPEUTICS INC | NOTE 1.250% 9/1 | 803607AD2 | 51,522,255 | 50,666,000 | PRN | SOLE | NONE | 50,666,000 | 0 | 0 | |
| SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | 11,082,800 | 515,000 | SH | SOLE | NONE | 515,000 | 0 | 0 | |
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | 11,419,240 | 280,158 | SH | SOLE | NONE | 280,158 | 0 | 0 | |
| TANDEM DIABETES CARE INC | NOTE 1.500% 5/0 | 875372AB0 | 67,178,721 | 71,051,000 | PRN | SOLE | NONE | 71,051,000 | 0 | 0 | |
| TERNS PHARMACEUTICALS INC | COM | 880881107 | 15,044,145 | 2,318,050 | SH | SOLE | NONE | 2,318,050 | 0 | 0 | |
| THERMO FISHER SCIENTIFIC INC | COM | 883556102 | 40,206,812 | 75,749 | SH | SOLE | NONE | 75,749 | 0 | 0 | |
| THIRD HARMONIC BIO INC | COM | 88427A107 | 14,436,717 | 1,316,018 | SH | SOLE | NONE | 1,316,018 | 0 | 0 | |
| TOURMALINE BIO INC | COM | 89157D105 | 23,740,548 | 906,820 | SH | SOLE | NONE | 906,820 | 0 | 0 | |
| TRANSMEDICS GROUP INC | COM | 89377M109 | 9,290,140 | 117,701 | SH | SOLE | NONE | 117,701 | 0 | 0 | |
| TRAVERE THERAPEUTICS INC | NOTE 2.500% 9/1 | 761299AB2 | 47,699,190 | 56,031,000 | PRN | SOLE | NONE | 56,031,000 | 0 | 0 | |
| TRAVERE THERAPEUTICS INC | NOTE 2.250% 3/0 | 89422GAA5 | 11,121,000 | 16,850,000 | PRN | SOLE | NONE | 16,850,000 | 0 | 0 | |
| VAXCYTE INC | COM | 92243G108 | 81,009,802 | 1,289,965 | SH | SOLE | NONE | 1,289,965 | 0 | 0 | |
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 7,037,162 | 323,102 | SH | SOLE | NONE | 323,102 | 0 | 0 | |
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 75,875,145 | 1,647,311 | SH | SOLE | NONE | 1,647,311 | 0 | 0 | |